Bracco Imaging has launched a new effort at its Switzerland-based R&D center to evaluate gas-filled microbubbles, usually used for diagnostic imaging, as a delivery vehicle for personalized gene therapies to treat chronic dysfunctional diseases linked to lipid metabolism.
The research project is part of a deal that Bracco signed with startup SonoGene, which is developing platforms for the therapeutic delivery of genes and drugs using ultrasound-triggered microbubble delivery systems.
Get the full story at our sister site, Drug Delivery Business News.